1887

Journal of General Virology header logo

Volume 103, Issue 11

A link between severe hepatitis in children and adenovirus 41 and adeno-associated virus 2 infections Open Access

Abstract

Over the past few months there have been reports of severe acute hepatitis in several hundred, otherwise healthy, immunocompetent young children. Several deaths have been recorded and a relatively large proportion of the patients have needed liver transplants. Most of the cases, so far, have been seen in the UK and in North America, but it has also been reported in many other European countries, the Middle East and Asia. Most common viruses have been ruled out as a causative agent; hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) were not detected, nor were Epstein–Barr virus (EBV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV) in many cases. A small proportion of the children had been infected with SARS-CoV-2 but these seem to be in a minority; similarly, almost none of the children had been vaccinated against COVID-19. Significantly, many of the patients were infected with adenovirus 41 (HAdV-F41). Previously, HAdV-41 had not been linked to hepatitis and is usually considered to cause gastroenteritis in both immunocompetent and immunocompromised patients. In two most recent studies, adeno-associated virus 2 (AAV2) was detected in almost all patients, together with species C and F HAdVs and human herpesvirus 6B (HHV6B). Here, I discuss the possibility that a change in tropism of HAdV-41 and changes in AAV2 may be responsible for their links to acute hepatitis.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): AAV2 , acute hepatitis , adeno-associated virus 2 , adenovirus , adenovirus 41 , childhood hepatitis and HAdV-F41
© 2022 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001783
2022-11-11
2024-04-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/103/11/jgv001783.html?itemId=/content/journal/jgv/10.1099/jgv.0.001783&mimeType=html&fmt=ahah

References

  1. Goodman B. Global toll of sudden, mysterious hepatitis in children rises to 650 cases. CNN 2022 https://ksltv.com/494167/global-toll-of-sudden-mysterious-hepatitis-in-children-rises-to-650-cases/
     [Google Scholar]
  2. Baker JM, Buchfellner M, Britt W, Sanchez V, Potter JL et al. Acute hepatitis and adenovirus infection among children - Alabama, October 2021- February 2022. MMWR Morb Mortal Wkly Rep 2022; 71:638–640 [View Article]
     [Google Scholar]
  3. Marsh K, Tayler R, Pollock L, Roy K, Lakha F et al. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022. Euro Surveill 2022; 27:15 [View Article]
     [Google Scholar]
  4. World Health Organization Disease Outbreak News; Multi-Country – Acute, severe hepatitis of unknown origin in children; 2022Apr23 https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376
  5. UK Health Security Agency Technical briefing 1: investigation into acute hepatitis of unknown aetiology in children in England. UKHSA publication gateway number GOV-12076.
  6. Walter C. 2022 https://www.channelnewsasia.com/commentary/hepatitis-liver-children-infant-outbreak-covid-vaccine-2659036
  7. Samarasekera U. Mystery outbreak of severe acute hepatitis in children. Lancet Gastroenterol Hepatol 2022; 7:601 [View Article]
     [Google Scholar]
  8. European Centre for Disease Control Increase in severe acute hepatitis cases of unknown aetiology in children Stockholm: ECDC; 2022
     [Google Scholar]
  9. Lutmer H, Carlson R. 2022; Acute Hepatitis Children Cases 2022. https://www.precisionvaccinations.com/adenovirus-hepatitis-cases-children-2022
  10. Brodin P, Arditi M. Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens. Lancet Gastroenterol Hepatol 2022; 7:594–595 [View Article] [PubMed]
     [Google Scholar]
  11. Binnicker M. Adenovirus or Covid-19: what is behind the outbreak in child hepatitis cases?; 2022 https://www.forbes.com/sites/coronavirusfrontlines/2022/05/19/adenovirus-or-covid-19-what-is-behind-the-outbreak-in-child-hepatitis-cases/?sh=1261a7872073
  12. Bonifield J, Tucker E. 2022; 1 death, 17 liver transplants in multi-country outbreak of hepatitis in children, WHO says. CNN Health https://edition.cnn.com/2022/04/23/health/multi-country-outbreak-of-hepatitis-in-children/index.html
     [Google Scholar]
  13. Ho A, Orton R, Tayler R, Asamaphan P, Tong L et al. Adeno-associated virus 2 infection in children with non-A-E hepatitis. Infectious Diseases 2022 [View Article]
     [Google Scholar]
  14. Morfopoulou S, Buddle S, Torres Montaguth OE, Atkinson L, Guerra-Assunção JA et al. Genomic investigations of acute hepatitis of unknown aetiology in children.. Infectious Diseases 2022 [View Article]
     [Google Scholar]
  15. Muzyczka N, Berns K. Parvoviridae: the viruses and their replication. Fields Virol 2001; 2:2327–2359
     [Google Scholar]
  16. Kerr JR, Cotmore SF, Bloom ME, Bloom R, Linden RM et al. eds Parvoviruses London: Hodder Arnold Publication; 2006
     [Google Scholar]
  17. Wold WSM. Adenoviruses. In Knipe D, Howley P. eds Fields’ Virology, 6th ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2013 pp 1731–1732
     [Google Scholar]
  18. Robinson CM, Singh G, Lee JY, Dehghan S, Rajaiya J et al. Molecular evolution of human adenoviruses. Sci Rep 2013; 3:1812 [View Article]
     [Google Scholar]
  19. Dhingra A, Hage E, Ganzenmueller T, Böttcher S, Hofmann J et al. Molecular evolution of human adenovirus (HAdV) species C. Sci Rep 2019; 9:1039 [View Article]
     [Google Scholar]
  20. Tiemessen CT, Kidd AH. The subgroup F adenoviruses. J Gen Virol 1995; 76 (Pt 3):481–497 [View Article] [PubMed]
     [Google Scholar]
  21. Mautner V, Steinthorsdottir V, Bailey A. Enteric adenoviruses. Curr Top Microbiol Immunol 1995; 199 (Pt 3):229–282 [View Article] [PubMed]
     [Google Scholar]
  22. Kidd AH, Chrystie IL, Banatvala JE, Hawkins G. Infection by fastidious enteric adenoviruses in childhood. Lancet 1981; 2:371–372 [View Article] [PubMed]
     [Google Scholar]
  23. Mautner V, Mackay N, Steinthorsdottir V. Complementation of enteric adenovirus type 40 for lytic growth in tissue culture by E1B 55K function of adenovirus types 5 and 12. Virology 1989; 171:619–622 [View Article] [PubMed]
     [Google Scholar]
  24. Avvakumov N, Kajon AE, Hoeben RC, Mymryk JS. Comprehensive sequence analysis of the E1A proteins of human and simian adenoviruses. Virology 2004; 329:477–492 [View Article] [PubMed]
     [Google Scholar]
  25. Blackford AN, Grand RJA. Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation. J Virol 2009; 83:4000–4012 [View Article] [PubMed]
     [Google Scholar]
  26. Kosulin K. Intestinal HAdV infection: tissue specificity, persistence, and implications for antiviral therapy. Viruses 2019; 11:E804 [View Article]
     [Google Scholar]
  27. Lion T. Adenovirus persistence, reactivation, and clinical management. FEBS Lett 2019; 593:3571–3582 [View Article] [PubMed]
     [Google Scholar]
  28. Lynch JP, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med 2016; 37:586–602 [View Article]
     [Google Scholar]
  29. Yabe Y, Trentin JJ, Taylor G. Cancer induction in hamsters by human type 12 adenovirus. Effect of age and of virus dose. Exp Biol Med 1962; 111:343–344 [View Article]
     [Google Scholar]
  30. Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev 1992; 5:262–274 [View Article] [PubMed]
     [Google Scholar]
  31. Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev 2014; 27:441–462 [View Article] [PubMed]
     [Google Scholar]
  32. Kosulin K, Berkowitsch B, Matthes S, Pichler H, Lawitschka A et al. Intestinal adenovirus shedding before allogeneic stem cell transplantation is a risk factor for invasive infection post-transplant. EBioMedicine 2018; 28:114–119 [View Article]
     [Google Scholar]
  33. Schaberg KB, Kambham N, Sibley RK, Higgins JPT. Adenovirus hepatitis: clinicopathologic analysis of 12 consecutive cases from a single institution. Am J Surg Pathol 2017; 41:810–819 [View Article]
     [Google Scholar]
  34. Khalifa A, Andreias L, Velpari SJ. Adenovirus hepatitis in immunocompetent adults. J Investig Med High Impact Case Rep 2022; 10:23247096221079190 [View Article]
     [Google Scholar]
  35. Amdani S, Sathyaprasad A, Badheka A, Queliz T, Sharma J, Mendez M. 2012; Adenoviral hepatitis in an immunocompetent child. https://www.contemporarypediatrics.com
  36. Ozbay Hoşnut F, Canan O, Ozçay F, Bilezikçi B. Adenovirus infection as possible cause of acute liver failure in a healthy child: a case report. Turk J Gastroenterol 2008; 19:281–283 [PubMed]
     [Google Scholar]
  37. Rocholl C, Gerber K, Daly J, Pavia AT, Byington CL. Adenoviral infections in children: the impact of rapid diagnosis. Pediatrics 2004; 113:e51–6 [View Article]
     [Google Scholar]
  38. Ronan BA, Agrwal N, Carey EJ, De Petris G, Kusne S et al. Fulminant hepatitis due to human adenovirus. Infection 2014; 42:105–111 [View Article] [PubMed]
     [Google Scholar]
  39. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275:1320–1323 [View Article]
     [Google Scholar]
  40. Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM et al. The coxsackievirus-adenovirus receptor protein can function as A cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 1998; 72:7909–7915 [View Article]
     [Google Scholar]
  41. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci 1997; 94:3352–3356 [View Article]
     [Google Scholar]
  42. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9:1408–1412 [View Article] [PubMed]
     [Google Scholar]
  43. Stasiak AC, Stehle T. Human adenovirus binding to host cell receptors: a structural view. Med Microbiol Immunol 2020; 209:325–333 [View Article] [PubMed]
     [Google Scholar]
  44. Kidd AH, Chroboczek J, Cusack S, Ruigrok RW. Adenovirus type 40 virions contain two distinct fibers. Virology 1993; 192:73–84 [View Article] [PubMed]
     [Google Scholar]
  45. Nakamura T, Sato K, Hamada H. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber. J Virol 2003; 77:2512–2521 [View Article]
     [Google Scholar]
  46. Rodríguez E, Romero C, Río A, Miralles M, Raventós A et al. Short-fiber protein of ad40 confers enteric tropism and protection against acidic gastrointestinal conditions. Hum Gene Ther Methods 2013; 24:195–204 [View Article] [PubMed]
     [Google Scholar]
  47. Rajan A, Persson BD, Frängsmyr L, Olofsson A, Sandblad L et al. Enteric species F human adenoviruses use laminin-binding integrins as co-receptors for infection of Ht-29 cells. Sci Rep 2018; 8:10019 [View Article]
     [Google Scholar]
  48. Smith JG, Silvestry M, Lindert S, Lu W, Nemerow GR et al. Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog 2010; 6:e1000959 [View Article]
     [Google Scholar]
  49. Samulski RJ, Muzyczka N. AAV-mediated gene therapy for research and therapeutic purposes. Annu Rev Virol 2014; 1:427–451 [View Article]
     [Google Scholar]
  50. Casto BC, Atchison RW, Hammon WM. Studies on the relationship between adeno-associated virus type I (AAV-1) and adenoviruses. I. Replication of AAV-1 in certain cell cultures and its effect on helper adenovirus. Virology 1967; 32:52–59 [View Article] [PubMed]
     [Google Scholar]
  51. Buller RM, Janik JE, Sebring ED, Rose JA. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol 1981; 40:241–247 [View Article] [PubMed]
     [Google Scholar]
  52. McCarty DM, Young SM, Samulski RJ. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 2004; 38:819–845 [View Article] [PubMed]
     [Google Scholar]
  53. Hüser D, Gogol-Döring A, Lutter T, Weger S, Winter K et al. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome. PLoS Pathog 2010; 6:e1000985 [View Article]
     [Google Scholar]
  54. Schnepp BC, Jensen RL, Chen CL, Johnson PR, Clark KR. Characterization of adeno-associated virus genomes isolated from human tissues. J Virol 2005; 79:14793–14803 [View Article] [PubMed]
     [Google Scholar]
  55. Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 2004; 78:6381–6388 [View Article] [PubMed]
     [Google Scholar]
  56. Heugel J, Boeckh M, Huang ML, Dierks B, Hackman R et al. Detection of adeno-associated virus viremia in hematopoietic cell transplant recipients. J Infect Dis 2011; 204:1746–1749 [View Article] [PubMed]
     [Google Scholar]
  57. La Bella T, Imbeaud S, Peneau C, Mami I, Datta S et al. Adeno-associated virus in the liver: natural history and consequences in tumour development. Gut 2020; 69:737–747 [View Article] [PubMed]
     [Google Scholar]
  58. Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet 2015; 47:1187–1193 [View Article] [PubMed]
     [Google Scholar]
  59. Berns KI, Byrne BJ, Flotte TR, Gao G, Hauswirth WW et al. Adeno-associated virus type 2 and hepatocellular carcinoma?. Hum Gene Ther 2015; 26:779–781 [View Article]
     [Google Scholar]
  60. Qiu J, Pintel D. Processing of adeno-associated virus RNA. Front Biosci 2008; 13:3101–3115 [View Article] [PubMed]
     [Google Scholar]
  61. Mietzsch M, Pénzes JJ, Agbandje-McKenna M. Twenty-five years of structural parvovirology. Viruses 2019; 11:E362 [View Article]
     [Google Scholar]
  62. Galibert L, Hyvönen A, Eriksson RAE, Mattola S, Aho V et al. Functional roles of the membrane-associated AAV protein MAAP. Sci Rep 2021; 11:21698 [View Article]
     [Google Scholar]
  63. DiMattia MA, Nam H-J, Van Vliet K, Mitchell M, Bennett A et al. Structural insight into the unique properties of adeno-associated virus serotype 9. J Virol 2012; 86:6947–6958 [View Article] [PubMed]
     [Google Scholar]
  64. Kern A, Schmidt K, Leder C, Müller OJ, Wobus CE et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol 2003; 77:11072–11081 [View Article] [PubMed]
     [Google Scholar]
  65. Tseng YS, Agbandje-McKenna M. Mapping the AAV capsid host antibody response toward the development of second generation gene delivery vectors. Front Immunol 2014; 5:9 [View Article]
     [Google Scholar]
  66. Meyer NL, Chapman MS. Adeno-associated virus (AAV) cell entry: structural insights. Trends Microbiol 2022; 30:432–451 [View Article] [PubMed]
     [Google Scholar]
  67. Wander P, Epstein M, Bernstein D. COVID-19 presenting as acute hepatitis. Am J Gastroenterol 2020; 115:941–942 [View Article]
     [Google Scholar]
  68. Sun J, Aghemo A, Forner A, Valenti L. COVID-19 and liver disease. Liver Int 2020; 40:1278–1281 [View Article]
     [Google Scholar]
  69. Brisca G, Mallamaci M, Tardini G, Martino L, Chianucci B et al. SARS-CoV-2 infection may present as acute hepatitis in children. Pediatr Infect Dis J 2021; 40:e214–e215 [View Article]
     [Google Scholar]
  70. Hsu HL, Brown A, Loveland AB, Lotun A, Xu M et al. Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties. Nat Commun 2020; 11:3279 [View Article]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001783
Loading

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error